Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

SPE2DX15D9000

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$499,493,731.00
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2DX
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
PIID
SPE2DX15D9000
Award type code
B
Actions
22 · Nov 13, 2014 to Oct 1, 2025
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History22

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 1, 2025FY2026P00024D$0.00
Sep 3, 2025FY2025P00023D$0.00
Apr 22, 2025FY2025P00022D$0.00
Oct 8, 2024FY2025P00021D$0.00
Aug 13, 2024FY2024P00019B$0.00
May 21, 2024FY2024P00018D$0.00
Aug 23, 2023FY2023P00017D$0.00
Jul 10, 2023FY2023P00016D$0.00
Feb 9, 2023FY2023P00015B$0.00
Sep 15, 2022FY2022P00014B$0.00
Apr 27, 2022FY2022P00013G$0.00
Aug 26, 2021FY2021P00012B$0.00
Jul 22, 2021FY2021P00011B$0.00
Aug 12, 2020FY2020P00010B$0.00
Dec 19, 2019FY2020P00009B$0.00
Nov 4, 2019FY2020P00008G$0.00
Jul 17, 2019FY2019P00007M$0.00
Aug 2, 2018FY2018P00006M$0.00
Oct 31, 2017FY2018P00005M$0.00
Sep 13, 2017FY2017P00004M$0.00
May 3, 2017FY2017P00003G$0.00
Nov 13, 2014FY20150—$0.00

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.